Search Medical Condition
Please enter condition
Please choose location from dropdown

Trinec, Czech Republic Clinical Trials

A listing of Trinec, Czech Republic clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction

Randomization to study drugs shall be performed using an online database system for data collection; the assigned arm and the randomisation code will be generated after entering basic patient data based on a predefined randomization scheme. Concomitant therapy. Acetylsalicylic acid - 500 mg i.v. initial dose, and then 100 mg ...

Phase

0.0 miles

Learn More »

A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat Inhaler

Open-label observational study which includes COPD patients that are receiving treatment with Spiolto Respimat for approximately 6 weeks, which is the average time between two medical consultations.

Phase N/A

6.76 miles

Learn More »

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

The aim of the study is to evaluate efficacy and safety of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with preserved ejection fraction

Phase

7.2 miles

Learn More »

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

Phase

7.2 miles

Learn More »

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.

Phase

7.2 miles

Learn More »